Abbott clinical biochemical aspartate transaminase (activation) test set - Taiwan Registration 3d11dd550c31e263049dd654e8aa642d
Access comprehensive regulatory information for Abbott clinical biochemical aspartate transaminase (activation) test set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3d11dd550c31e263049dd654e8aa642d and manufactured by FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
3d11dd550c31e263049dd654e8aa642d
DHA05602584607
Product Details
This product is used in conjunction with the AEROSET system and the ARCHITECT c system (c4000, c8000, c16000) to quantitatively detect aspartate transaminases in human serum or plasma. Performance change: Removed the AEROSET system.
A Clinical chemistry and clinical toxicology
A.1100 ๅคฉ้ๅฌ่บ้ ธ่ฝ่บ้ ถ่ฉฆ้ฉ็ณป็ตฑ
Input;; Contract manufacturing
Dates and Status
Jan 08, 2014
Jan 08, 2029

